Increasingly powerful opioid antagonists are not necessary

por Hill, Lucas G., Zagorski, Claire M., Loera, Lindsey J.
Publicado 2022

Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

por Zagorski, Claire M., Hosey, Rebecca A., Moraff, Christopher, Ferguson, Aaron, Figgatt, Mary, Aronowitz, Shoshana, Stahl, Natalie E., Hill, Lucas G., McElligott, Zoe, Dasgupta, Nabarun
Publicado 2023

Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

por Zagorski, Claire M., Hosey, Rebecca A., Moraff, Christopher, Ferguson, Aaron, Figgatt, Mary, Aronowitz, Shoshana, Stahl, Natalie E., Hill, Lucas G., McElligott, Zoe, Dasgupta, Nabarun
Publicado 2023

“We do it ourselves”: strengths and opportunities for improving the practice of harm reduction

por Claborn, Kasey, Samora, Jake, McCormick, Katie, Whittfield, Quanisha, Courtois, Frederic, Lozada, Kyle, Sledge, Daniel, Burwell, Annie, Chavez, Sandra, Bailey, Jamie, Bailey, Chris, Pederson, Chelsea Dalton, Zagorski, Claire, Hill, Lucas, Conway, Fiona N., Steiker, Lori Holleran, Cance, Jessica, Potter, Jennifer
Publicado 2023